Cargando…

Human cancer stem cells are a target for cancer prevention using (−)-epigallocatechin gallate

PURPOSE: Our previous experiments show that the main constituent of green-tea catechins, (−)-epigallocatechin gallate (EGCG), completely prevents tumor promotion on mouse skin initiated with 7,12-dimethylbenz(a)anthracene followed by okadaic acid and that EGCG and green tea extract prevent cancer de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujiki, Hirota, Sueoka, Eisaburo, Rawangkan, Anchalee, Suganuma, Masami
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Review – Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693978/ https://www.ncbi.nlm.nih.gov/pubmed/28942499 http://dx.doi.org/10.1007/s00432-017-2515-2

Ejemplares similares

Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells
por: Fujiki, Hirota, et al.
Publicado: (2018)

The concept of the okadaic acid class of tumor promoters is revived in endogenous protein inhibitors of protein phosphatase 2A, SET and CIP2A, in human cancers
por: Fujiki, Hirota, et al.
Publicado: (2018)

(−)-Epigallocatechin gallate inhibits stemness and tumourigenicity stimulated by AXL receptor tyrosine kinase in human lung cancer cells
por: Namiki, Kozue, et al.
Publicado: (2020)

Primary Cancer Prevention by Green Tea, and Tertiary Cancer Prevention by the Combination of Green Tea Catechins and Anticancer Compounds
por: Fujiki, Hirota, et al.
Publicado: (2015)

Phorbol esters in seed oil of Jatropha curcas L. (saboodam in Thai) and their association with cancer prevention: from the initial investigation to the present topics
por: Fujiki, Hirota, et al.
Publicado: (2017)

Role of TNF-α-Inducing Protein Secreted by Helicobacter pylori as a Tumor Promoter in Gastric Cancer and Emerging Preventive Strategies
por: Suganuma, Masami, et al.
Publicado: (2021)

Mechanisms of Growth Inhibition of Human Lung Cancer Cell Line, PC‐9, by Tea Polyphenols
por: Okabe, Sachiko, et al.
Publicado: (1997)

Cancer progression by the okadaic acid class of tumor promoters and endogenous protein inhibitors of PP2A, SET and CIP2A
por: Fujiki, Hirota, et al.
Publicado: (2023)

Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth
por: Rawangkan, Anchalee, et al.
Publicado: (2018)

Activation of Protein Kinase C by Mycobacterial Cord Factor, Trehalose 6‐Monomycolate, Resulting in Tumor Necrosis Factor‐α Release in Mouse Lung Tissues
por: Sueoka, Eisaburo, et al.
Publicado: (1995)

Disaccharide Esters Screened for Inhibition of Tumor Necrosis Factor‐α Release Are New Anti‐cancer Agents
por: Okabe, Sachiko, et al.
Publicado: (1999)

Antimicrobial Activity of the Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate (EGCG) against Clinical Isolates of Multidrug-Resistant Vibrio cholerae
por: Siriphap, Achiraya, et al.
Publicado: (2022)

Targeted nanoparticles encapsulating (−)-epigallocatechin-3-gallate for prostate cancer prevention and therapy
por: Sanna, Vanna, et al.
Publicado: (2017)

Significance of Heterogeneous Nuclear Ribonucleoprotein B1 as a New Early Detection Marker for Oral Squamous Cell Carcinoma
por: Goto, Yuri, et al.
Publicado: (1999)

Association of MTG8 (ETO/CDR), a Leukemia‐related Protein, with Serine/Threonine Protein Kinases and Heat Shock Protein HSP90 in Human Hematopoietic Cell Lines
por: Komori, Atsumasa, et al.
Publicado: (1999)

Inhibitory Effect of (—)‐Epigallocatechin Gallate on Carcinogenesis with N‐Ethyl‐N′‐nitro‐N‐nitrosoguanidine in Mouse Duodenum
por: Fujita, Yoshihiro, et al.
Publicado: (1989)

Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
por: Granja, Andreia, et al.
Publicado: (2016)

Epigallocatechin-3-Gallate Inhibits Stem-Like Inflammatory Breast Cancer Cells
por: Mineva, Nora D., et al.
Publicado: (2013)

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer
por: Wang, Liu-Xiang, et al.
Publicado: (2019)

Melatonin and (−)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer
por: Zhang, Lingyun, et al.
Publicado: (2019)

Preclinical Activities of Epigallocatechin Gallate in Signaling Pathways in Cancer
por: Sharifi-Rad, Mehdi, et al.
Publicado: (2020)

Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer
por: Toden, Shusuke, et al.
Publicado: (2016)

Enhancement of Cisplatin Sensitivity in Human Cervical Cancer: Epigallocatechin-3-Gallate
por: Kilic, Ulkan, et al.
Publicado: (2015)

Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL
por: Iida, Keisuke, et al.
Publicado: (2017)

Mechanistic Aspects of Green Tea as a Cancer Preventive: Effect of Components on Human Stomach Cancer Cell Lines
por: Okabe, Sachiko, et al.
Publicado: (1999)

Inhibitory Effects of (—)‐Epigallocatechin Gallate on Spontaneous Hepatoma in C3H/HeNCrj Mice and Human Hepatoma‐derived PLC/PRF/5 Cells
por: Nishida, Hiroshi, et al.
Publicado: (1994)

Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018)

Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats
por: Wang, Yu, et al.
Publicado: (2020)

Epigallocatechin-3-gallate and cancer: focus on the role of microRNAs
por: Wang, Chunguang, et al.
Publicado: (2023)

Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021)

Molecular Targets of Epigallocatechin—Gallate (EGCG): A Special Focus on Signal Transduction and Cancer
por: Negri, Aide, et al.
Publicado: (2018)

The Potential of Epigallocatechin Gallate (EGCG) in Targeting Autophagy for Cancer Treatment: A Narrative Review
por: Ferrari, Elena, et al.
Publicado: (2022)

Biophysical Approach to Mechanisms of Cancer Prevention and Treatment with Green Tea Catechins
por: Suganuma, Masami, et al.
Publicado: (2016)

Epigallocatechin-3-gallate enhances the osteoblastogenic differentiation of human adipose-derived stem cells
por: Zhang, Jing, et al.
Publicado: (2019)

Epigallocatechin gallate inhibits the growth and promotes the apoptosis of bladder cancer cells
por: Feng, Chenchen, et al.
Publicado: (2017)

The regulation of steroid receptors by epigallocatechin-3-gallate in breast cancer cells
por: Hallman, Kelly, et al.
Publicado: (2017)

Advanced Nanovehicles-Enabled Delivery Systems of Epigallocatechin Gallate for Cancer Therapy
por: Li, Kai, et al.
Publicado: (2020)

Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers
por: Huang, Yun-Ju, et al.
Publicado: (2020)

Nanocarriers Based on Gold Nanoparticles for Epigallocatechin Gallate Delivery in Cancer Cells
por: Cunha, Lídia, et al.
Publicado: (2022)

The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment
por: Marín, Víctor, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jmlisen6e7hucjh4rb8j3sq2hl